By Josh White
Date: Monday 01 Dec 2025
(Sharecast News) - Ixico strengthened its scientific advisory board on Monday, with the appointment of two leading global authorities in Alzheimer's and cerebrovascular disease, bolstering its strategy to expand biomarker innovation in dementia research.
| Correction: c.£1.5 million Contract Extension | 12-Feb-2026 | 08:48 | RNS |
| c.£1.5 million Contract Extension | 12-Feb-2026 | 07:00 | RNS |
| Appointment of Chief Commercial Officer | 05-Feb-2026 | 07:00 | RNS |
| Results of AGM | 23-Jan-2026 | 17:05 | RNS |
| Share option award | 09-Dec-2025 | 07:05 | RNS |
| One to watch: Phytopharm | 19-Jul-2011 | The Scotsman |
| Phytopharm soars 340% on drug trial | 15-Oct-2009 | The Independent |
| Need to know: InBev go ahead ... Citigroup job c... | 15-Nov-2008 | Times |
| Star puts $1m into UK drug research | 20-Jan-2008 | Sunday Times |
| Techmark at best level for five years | 19-Jan-2007 | Telegraph |
| Phytopharm | 04-Jul-2008 | The Independent |
| A desire to be in the Falkland Islands | 29-Feb-2008 | Times |
| Market report: Thursday latest | 28-Feb-2008 | Daily Mail |
| The Investment Column: Phytopharm | 19-Feb-2008 | The Independent |
| The Week Ahead: Take two... It's crunch time (ag... | 26-Nov-2007 | The Independent |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 8.88p |
| Change Today | 0.13p |
| % Change | 1.43 % |
| 52 Week High | 14.00 |
| 52 Week Low | 7.75 |
| Volume | 61,620 |
| Shares Issued | 92.67m |
| Market Cap | £8.22m |
| Beta | 0.68 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
You are here: research